As of February 10, 2023, the average one-year price target for Cyclo Therapeutics is $5.10. The forecasts range from a low of $5.05 to a high of $5.25. The average price target represents an increase ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Fintel reports that on September 27, 2023, Maxim Group upgraded their outlook for Cyclo Therapeutics Inc - (NASDAQ:CYTH) from Hold to Buy. As of March 27, 2023, the average one-year price target for ...

We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Cyclo Therapeutics, Inc. (NASDAQ:CYTH) stands against the other micro cap ...

Fintel reports that on August 27, 2024, Maxim Group downgraded their outlook for Cyclo Therapeutics (NasdaqCM:CYTH) from Buy to Hold. Analyst Price Forecast Suggests 152.33% Upside As of August 26, ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose ...

Lumen Technologies Inc. Annual stock financials by MarketWatch. View the latest CYTH financial statements, income statements and financial ratios.